DNTH Competitors & Alternatives
Compare Dianthus Therapeutics Inc. with similar stocks in the same industry
Biotechnology
DNTH
Main Stock$106.20
Tradestie Score
52
Market Cap
$1.55B
Revenue Growth
2.9%
Analyst Upside
+33.0%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$104.71
|
$6.64B | - | 62 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$118.64
|
$6.38B | - | 56 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$18.64
|
$6.03B | - | 44 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$51.72
|
$6.02B | - | 44 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$220.75
|
$5.92B | - | 56 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$53.89
|
$5.80B | 20.0 | 49 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$347.00
|
$5.20B | 43.3 | 47 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$59.47
|
$4.94B | - | 45 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$66.06
|
$4.93B | - | 42 | Compare |
More DNTH Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry